Validation of surrogate indexes of insulin sensitivity in acute phase of myocardial infarction based on euglycemic-hyperinsulinemic clamp

American Journal of Physiology - Endocrinology and Metabolism

Volumn 306, Issue 4, 2014, Pages

  Moura, Filipe A ^a   Carvalho, Luiz Sergio F ^a   Cintra, Riobaldo M R ^a   Martins, Naiara V ^b   Figueiredo, Valeria N ^a   Quinaglia e Silva, Jose C ^b,c   Almeida, Osorio L R ^b,c   Coelho, Otavio R ^a   Sposito, Andrei C ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

^c HOSPITAL DE BASE DO DISTRITO FEDERAL   (Brazil)

Author keywords

Euglycemic hyperinsulinemic clamp; Homeostatic model assessment; Insulin sensitivity; Myocardial infarction

Indexed keywords

EUGLYCEMIC HYPERINSULINEMIC CLAMP; HOMEOSTATIC MODEL ASSESSMENT; INSULIN SENSITIVITY; MYOCARDIAL INFARCTION;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FASTING; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION;

EID: 84894080913     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00566.2013     Document Type: Article

References (17)

1. Borai A, Livingstone C, Kaddam I, Ferns G. Selection of the appropriate method for the assessment of insulin resistance (Abstract). BMC Med Res Methodol 11: 158, 2011.
2. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355: 773-778, 2000.
3. Chen X, Ruiz J, Boden G. Release, oxidation, and reesterification of fatty acids from infused triglycerides: effect of heparin. Metabolism 44: 1590-1595, 1995.
4. Dandona P, Chaudhuri A, Ghanim H, Mohanty P. Insulin as an anti-inflammatory and antiatherogenic modulator. J Am Coll Cardiol 53: S14-S20, 2009.
5. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E214-E223, 1979.
6. Falciglia M. Causes and consequences of hyperglycemia in critical illness. Curr Opin Clin Nutr Metab Care 10: 498-503, 2007.
7. Goyal A, Mehta SR, Diaz R, Gerstein HC, Afzal R, Xavier D, Liu L, Pais P, Yusuf S. Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. Circulation 120: 2429-2437, 2009.
8. Heath DF. Glucose, insulin and other plasma metabolites shortly after injury. J Accid Emerg Med 11: 67-77, 1994.
9. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410, 2000.
10. Kuboki K, Jiang ZY, Takahara N, Ha SW, Igarashi M, Yamauchi T, Feener EP, Herbert TP, Rhodes CJ, King GL. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin. Circulation 101: 676-681, 2000.
11. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 21: 2191-2192, 1998.
12. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
13. Rabasa-Lhoret R, Bastard JP, Jan V, Ducluzeau PH, Andreelli F, Guebre F, Bruzeau J, Louche-Pellissier C, MaItrepierre C, Peyrat J, Chagne J, Vidal H, Laville M. Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. J Clin Endocrinol Metab 88: 4917-4923, 2003.
14. Sposito AC, Carvalho LS, Cintra RM, Araujo AL, Ono AH, Andrade JM, Coelho OR, Quinaglia e Silva JC, Brasilia Heart Study G. Rebound inflammatory response during the acute phase of myocardial infarction after simvastatin withdrawal. Atherosclerosis 207: 191-194, 2009.
15. Vetter NJ, Strange RC, Adams W, Oliver MF. Initial metabolic and hormonal response to acute myocardial infarction. Lancet 1: 284-288, 1974.
16. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 27: 1487-1495, 2004.
17. Zar JH. Comparing Two Correlation Coefficients. Englewood Cliffs, NJ: Prentice-Hall, 1999, p. 386-387.